nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiovascular Disease and Endometrial Cancer
|
Mehta, Puja K. |
|
2012 |
126 |
2 |
p. 171-173 3 p. |
artikel |
2 |
Cardiovascular disease is the leading cause of death among endometrial cancer patients
|
Ward, Kristy K. |
|
2012 |
126 |
2 |
p. 176-179 4 p. |
artikel |
3 |
Centralisation of services for gynaecological cancers — A Cochrane systematic review
|
Woo, Yin Ling |
|
2012 |
126 |
2 |
p. 286-290 5 p. |
artikel |
4 |
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review
|
Fruscio, Robert |
|
2012 |
126 |
2 |
p. 192-197 6 p. |
artikel |
5 |
Editorial Board
|
|
|
2012 |
126 |
2 |
p. i- 1 p. |
artikel |
6 |
Evaluation of Society of Gynecologic Oncologists (SGO) ovarian cancer quality surgical measures
|
Gogoi, Radhika P. |
|
2012 |
126 |
2 |
p. 217-219 3 p. |
artikel |
7 |
Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB‐dependent cyclin D1 signaling
|
Kuo, Sung-Hsin |
|
2012 |
126 |
2 |
p. 245-251 7 p. |
artikel |
8 |
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer
|
Dellinger, Thanh H. |
|
2012 |
126 |
2 |
p. 259-267 9 p. |
artikel |
9 |
HE4 is an independent prognostic marker in endometrial cancer patients
|
Mutz-Dehbalaie, Irene |
|
2012 |
126 |
2 |
p. 186-191 6 p. |
artikel |
10 |
Human Papilloma Virus infection in sexually active adolescent girls
|
Michala, Lina |
|
2012 |
126 |
2 |
p. 207-210 4 p. |
artikel |
11 |
Management of ovarian cancer has changed
|
Alouini, S. |
|
2012 |
126 |
2 |
p. 313- 1 p. |
artikel |
12 |
7 Methyl indole ethyl isothiocyanate causes ROS mediated apoptosis and cell cycle arrest in endometrial cancer cells
|
Kristjansdottir, Katrin |
|
2012 |
126 |
2 |
p. 252-258 7 p. |
artikel |
13 |
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers
|
Fader, Amanda Nickles |
|
2012 |
126 |
2 |
p. 180-185 6 p. |
artikel |
14 |
Molecularly targeted therapies in cervical cancer. A systematic review
|
Zagouri, Flora |
|
2012 |
126 |
2 |
p. 291-303 13 p. |
artikel |
15 |
Obesity: Too big a problem to ignore
|
Secord, Angeles Alvarez |
|
2012 |
126 |
2 |
p. 274-276 3 p. |
artikel |
16 |
Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma
|
Hyman, David M. |
|
2012 |
126 |
2 |
p. 224-228 5 p. |
artikel |
17 |
Ovarian low-grade serous carcinoma: A comprehensive update
|
Diaz-Padilla, Ivan |
|
2012 |
126 |
2 |
p. 279-285 7 p. |
artikel |
18 |
Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedule
|
Toita, Takafumi |
|
2012 |
126 |
2 |
p. 211-216 6 p. |
artikel |
19 |
p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy
|
Donà, Maria Gabriella |
|
2012 |
126 |
2 |
p. 198-202 5 p. |
artikel |
20 |
Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland
|
Koskela-Niska, Virpi |
|
2012 |
126 |
2 |
p. 241-244 4 p. |
artikel |
21 |
Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling
|
Pocobelli, Gaia |
|
2012 |
126 |
2 |
p. 229-235 7 p. |
artikel |
22 |
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB–IV
|
Meier, Werner |
|
2012 |
126 |
2 |
p. 236-240 5 p. |
artikel |
23 |
Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes
|
Peiretti, Michele |
|
2012 |
126 |
2 |
p. 220-223 4 p. |
artikel |
24 |
Re: “Pelvic exenteration with curative intent for recurrent uterine malignancies”
|
Khoury-Collado, Fady |
|
2012 |
126 |
2 |
p. 312-313 2 p. |
artikel |
25 |
Re: “Pelvic exenteration with curative intent for recurrent uterine malignancies”
|
Thomas, Gillian M. |
|
2012 |
126 |
2 |
p. 312- 1 p. |
artikel |
26 |
Response to: “Management of ovarian cancer has changed”
|
Barlin, Joyce N. |
|
2012 |
126 |
2 |
p. 314- 1 p. |
artikel |
27 |
Screening history preceding a diagnosis of cervical cancer in women age 65 and older
|
Dinkelspiel, Helen |
|
2012 |
126 |
2 |
p. 203-206 4 p. |
artikel |
28 |
Summary of the 2012 American Association for Cancer Research (AACR) Annual Meeting
|
Bae-Jump, Victoria |
|
2012 |
126 |
2 |
p. 174-175 2 p. |
artikel |
29 |
Susceptibility to cervical cancer: An overview
|
de Freitas, Antonio Carlos |
|
2012 |
126 |
2 |
p. 304-311 8 p. |
artikel |
30 |
Times have really changed!
|
Canis, Michel |
|
2012 |
126 |
2 |
p. 315- 1 p. |
artikel |
31 |
Time waits for no one
|
Martino, Martin A. |
|
2012 |
126 |
2 |
p. 315-316 2 p. |
artikel |
32 |
TRAIL-R3-related apoptosis: Epigenetic and expression analyses in women with ovarian neoplasia
|
Braga, Letícia da Conceição |
|
2012 |
126 |
2 |
p. 268-273 6 p. |
artikel |
33 |
Uterine artery-preserving laparoscopic radical trachelectomy for early cervical cancer: Technical aspects
|
Chang, Suk-Joon |
|
2012 |
126 |
2 |
p. 277-278 2 p. |
artikel |